565 research outputs found
Reproductive biology and parasite (Perkinsus marinus) prevalence in the eastern oyster, Crassostrea virginica, within a Georgia tidal river
Peer-reviewed. © F.X. O'Beirn et al., 1997. Reproduced with the permission of the executive editor of the JNCAS.Recruitment, in 1992, of the eastern oyster, Crassostrea virginica, at one site (Flume Dock) within the Sapelo Island National Estuarine Research Reserve (SINERR) was lower than other sampling sites. Recruitment allied with gametogenesis and parasite (Perkinsus marinus) prevalence within the oysters was examined in 1993, in an attempt to explain the differences observed the previous year. Sampling occurred at three sites (Marsh Landing, Jack Hammock, and Flume Dock) along the Duplin River within the SINERR. Oyster recruitment in 1993 was reduced in all sites within the SINERR. No oyster recruitment was recorded at the Flume Dock site during any monthly collections or on collectors deployed for the duration of the sampling study. Oysters developed gametogenically and spawned at the Marsh Landing site two weeks prior to their occurrence at the
Jack Hammock site. Gametogenic development in oysters at the Flume Dock site was retarded a further two weeks where the males appeared to spawn six weeks after the females, which could account for reduced recruitment levels at this site. Approximately, twice as many females as males occurred in all sites. Monthly sampling of prevalence and intensity of Perkinsus marinus (Dermo) revealed high levels of both parameters. Smaller oysters did display lower prevalences of Dermo than larger forms
The confined-deconfined Interface Tension and the Spectrum of the Transfer Matrix
The reduced tension of the interface between the confined and
the deconfined phase of pure gauge theory is related to the finite size
effects of the first transfer matrix eigenvalues. A lattice simulation of the
transfer matrix spectrum at the critical temperature yields
for . We found numerical evidence that
the deconfined-deconfined domain walls are completely wet by the confined
phase, and that the confined-deconfined interfaces are rough.Comment: 22 pages, LaTeX file with 4 ps figures included, HLRZ 92-47,
BUTP-92/3
Functional molecular mass of rat hepatic lipase in liver, adrenal gland and ovary is different
Lipoprotein lipase (LPL) is functionally active only as a dimer. It is
also generally assumed that the highly homologous hepatic lipase functions
as a dimer, but no clear evidence has been presented. A hepatic
lipase-like activity, also indicated as L-type lipase, is present in
adrenal and ovary tissues. This enzyme is thought to originate from the
liver and to be identical to hepatic lipase. We determined the functional
molecular mass of hepatic lipase in rat liver, adrenal gland and ovary by
radiation inactivation, a method for determining the functional size of a
protein without the need of prior purification. Samples were exposed to
ionizing radiation at -135 degrees C. Hepatic lipase activity in liver
homogenate showed a single exponential decay. The functional molecular
mass was calculated to be 63 +/- 10 kDa. Hepatic lipase activity in
adrenal homogenate was found to have a functional molecular mass of 117
+/- 16 kDa. The functional molecular masses of the lipases partially
purified from rat liver perfusate, adrenal homogenate or ovarian
homogenate showed the same pattern, a target mass for the liver enzyme of
56 +/- 6 kDa and a target mass of 117 +/- 14 kDa for the enzyme from
adrenal gland or ovary. In Western blot analysis the mass of the
structural units of hepatic lipase in liver was 57 kDa and in adrenal and
ovary tissue 51 kDa. We conclude that the functional unit of hepatic
lipase in the liver is a monomer. The enzyme in adrenal gland and ovary is
different from the liver and the functional unit may be a dimer
Compressibility and Electronic Structure of MgB2 up to 8 GPa
The lattice parameters of MgB2 up to pressures of 8 GPa were determined using
high-resolution x-ray powder diffraction in a diamond anvil cell. The bulk
modulus, B0, was determined to be 151 +-5 GPa. Both experimental and
first-principles calculations indicate nearly isotropic mechanical behavior
under pressure. This small anisotropy is in contrast to the 2 dimensional
nature of the boron pi states. The pressure dependence of the density of states
at the Fermi level and a reasonable value for the average phonon frequency
account within the context of BCS theory for the reduction of Tc under
pressure.Comment: REVTeX file. 4 pages, 4 figure
Analytical Evaluation of Hierarchical Planning Systems
Hierarchical planning systems have become popular for multilevel decision problems. After reviewing the concept of hierarchical planning and citing some examples, the authors describe a method for analytic evaluation of a hierarchical planning system. They show that multilevel decision problems can be nicely modeled as multistage stochastic programs. Then any hierarchical planning system can be measured against the yardstick of optimality in this stochastic program. They demonstrate this approach on a hierarchical system that can be shown to be asymptotically optimal for a job shop design/scheduling problem
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer:Results from the drug rediscovery protocol (DRUP)
Background: In 2–5% of patients with colorectal cancer (CRC), human epidermal growth factor 2 (HER2) is amplified or overexpressed. Despite prior evidence that anti-HER2 therapy confers clinical benefit (CB) in one-third of these patients, it is not approved for this indication in Europe. In the Drug Rediscovery Protocol (DRUP), patients are treated with off-label drugs based on their molecular profile. Here, we present the results of the cohort ‘trastuzumab/pertuzumab for treatment-refractory patients with RAS/BRAF-wild-type HER2amplified metastatic CRC (HER2+mCRC)’. Methods: Patients with progressive treatment-refractory RAS/BRAF-wild-type HER2+mCRC with measurable disease were included for trastuzumab plus pertuzumab treatment. Primary endpoints of DRUP are CB (defined as confirmed objective response (OR) or stable disease (SD) ≥ 16 weeks) and safety. Patients were enrolled using a Simon-like 2-stage model, with 8 patients in stage 1 and 24 patients in stage 2 if at least 1/8 patients had CB. To identify biomarkers for response, whole genome sequencing (WGS) was performed on pre-treatment biopsies. Results: CB was observed in 11/24 evaluable patients (46%) with HER2+mCRC, seven patients achieved an OR (29%). Median duration of response was 8.4 months. Patients had undergone a median of 3 prior treatment lines. Median progression-free survival and overall survival were 4.3 months (95% CI 1.9–10.3) and 8.2 months (95% CI 7.2–14.7), respectively. No unexpected toxicities were observed. WGS provided potential explanations for resistance in 3/10 patients without CB, for whom WGS was available. Conclusions: The results of this study confirm a clinically significant benefit of trastuzumab plus pertuzumab treatment in patients with HER2+mCRC.</p
- …